Swedbank
INDV icon

Swedbank’s Indivior Pharmaceuticals INDV Stock Holding History

Swedbank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
249,000
+154,000
+162% +$5.59M 0.01% 513
2026
Q1 		$2.9M Buy
+95,000
New +$3.14M ﹤0.01% 611

Other funds holding INDV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Swedbank's INDV Position: Q2 2026 in Review

Swedbank increased its Indivior Pharmaceuticals (INDV) stake by 162% in Q2 2026, buying an estimated $5.59M and bringing the position to 249,000 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #513.

Swedbank first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 70 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Swedbank held 249,000 shares of Indivior Pharmaceuticals worth $10.2M as of Q2 2026.
  • Swedbank bought 154,000 Indivior Pharmaceuticals shares in Q2 2026, an estimated $5.59M.
  • Indivior Pharmaceuticals made up 0.01% of Swedbank's portfolio in Q2 2026, its #513 holding.
  • Swedbank first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 70 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.